Crestline Management, LP - TETRAPHASE PHARMACEUTICALS I ownership

Back to all holdings Add to watchlist

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2017. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Crestline Management, LP ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2017$1,151,000
+135.4%
161,403
+203.1%
0.15%
+73.0%
Q1 2017$489,000–53,250–0.09%–
 Download
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2017
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders